Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of “Hold” by Brokerages

Shares of Teladoc Health, Inc. (NYSE:TDOC) have earned an average recommendation of “Hold” from the seventeen analysts that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and five have assigned a buy rating to the company. The average 12-month target price among analysts that have covered the stock in the last year is $7.4333.

Several analysts have recently commented on the company. JPMorgan Chase & Co. decreased their price objective on Teladoc Health from $9.00 to $7.00 and set a “neutral” rating for the company in a report on Friday, March 13th. Deutsche Bank Aktiengesellschaft upgraded Teladoc Health from a “hold” rating to a “buy” rating and set a $11.00 target price on the stock in a research note on Tuesday, March 10th. Citigroup upped their target price on Teladoc Health from $6.00 to $7.00 and gave the company a “neutral” rating in a research report on Tuesday, May 5th. Barclays decreased their price target on Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating for the company in a research note on Thursday, March 26th. Finally, Weiss Ratings upgraded Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, May 22nd.

Teladoc Health Trading Down 0.1%

NYSE TDOC opened at $9.19 on Monday. Teladoc Health has a 52 week low of $4.40 and a 52 week high of $9.77. The company has a 50 day moving average price of $7.19 and a 200 day moving average price of $6.29. The company has a quick ratio of 2.72, a current ratio of 2.80 and a debt-to-equity ratio of 0.75. The firm has a market cap of $1.66 billion, a PE ratio of -9.47 and a beta of 2.10.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.01). Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The firm had revenue of $613.85 million during the quarter, compared to analyst estimates of $611.04 million. During the same quarter last year, the business earned ($0.53) earnings per share. Teladoc Health’s revenue was down 2.5% on a year-over-year basis. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. As a group, sell-side analysts forecast that Teladoc Health will post -0.92 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In related news, insider Adam C. Vandervoort sold 7,906 shares of Teladoc Health stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total value of $60,322.78. Following the completion of the sale, the insider directly owned 110,261 shares in the company, valued at $841,291.43. This trade represents a 6.69% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Fernando M. Rodrigues sold 5,677 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $43,315.51. Following the sale, the insider directly owned 9,572 shares in the company, valued at approximately $73,034.36. This represents a 37.23% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 39,195 shares of company stock valued at $299,058. Company insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Large investors have recently made changes to their positions in the stock. EverSource Wealth Advisors LLC increased its position in shares of Teladoc Health by 694.5% in the 1st quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 4,945 shares during the period. PNC Financial Services Group Inc. lifted its position in Teladoc Health by 177.7% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after acquiring an additional 2,810 shares during the period. IFP Advisors Inc lifted its position in Teladoc Health by 412.1% during the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock worth $31,000 after acquiring an additional 3,210 shares during the period. International Assets Investment Management LLC purchased a new stake in Teladoc Health during the 4th quarter valued at about $45,000. Finally, Van ECK Associates Corp grew its stake in Teladoc Health by 101.4% during the 4th quarter. Van ECK Associates Corp now owns 9,150 shares of the health services provider’s stock valued at $64,000 after purchasing an additional 4,607 shares during the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.